PHAT icon

Phathom Pharmaceuticals
PHAT

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$25
90% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Guggenheim
Guggenheim
Yatin Suneja
33% 1-yr PHAT win rate
27 Feb ‘26 1 month ago